These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6734225)
1. Long-term follow-up of newborns with persistent pulmonary hypertension. Bernbaum JC; Russell P; Sheridan PH; Gewitz MH; Fox WW; Peckham GJ Crit Care Med; 1984 Jul; 12(7):579-83. PubMed ID: 6734225 [TBL] [Abstract][Full Text] [Related]
2. Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study. Nakanishi H; Suenaga H; Uchiyama A; Kusuda S; Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F554-F561. PubMed ID: 29298856 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy. Ferrara B; Johnson DE; Chang PN; Thompson TR J Pediatr; 1984 Sep; 105(3):457-61. PubMed ID: 6432990 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Hilgendorff A; Apitz C; Bonnet D; Hansmann G Heart; 2016 May; 102 Suppl 2():ii49-56. PubMed ID: 27053698 [TBL] [Abstract][Full Text] [Related]
5. Persistent pulmonary hypertension of the newborn. Fuloria M; Aschner JL Semin Fetal Neonatal Med; 2017 Aug; 22(4):220-226. PubMed ID: 28342684 [TBL] [Abstract][Full Text] [Related]
6. High frequency oscillatory ventilation in newborns with idiopathic persistent pulmonary hypertension. Ng PC; Hui J; Lewindon PJ; Cheung KL; Wong W Singapore Med J; 1995 Oct; 36(5):517-20. PubMed ID: 8882538 [TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Risk Factors for Developing Pulmonary Hypertension in Children with Down Syndrome. Bush D; Galambos C; Ivy DD; Abman SH; Wolter-Warmerdam K; Hickey F J Pediatr; 2018 Nov; 202():212-219.e2. PubMed ID: 30025669 [TBL] [Abstract][Full Text] [Related]
8. Creation of a functional Potts shunt by stenting the persistent arterial duct in newborns and infants with suprasystemic pulmonary hypertension of various etiologies. Latus H; Apitz C; Moysich A; Kerst G; Jux C; Bauer J; Schranz D J Heart Lung Transplant; 2014 May; 33(5):542-6. PubMed ID: 24630407 [TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide therapy decreases the risk of cerebral palsy in preterm infants with persistent pulmonary hypertension of the newborn. Tanaka Y; Hayashi T; Kitajima H; Sumi K; Fujimura M Pediatrics; 2007 Jun; 119(6):1159-64. PubMed ID: 17545384 [TBL] [Abstract][Full Text] [Related]
10. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease. Zaidi AN; Dettorre MD; Ceneviva GD; Thomas NJ Pediatr Pulmonol; 2005 Sep; 40(3):265-9. PubMed ID: 15830393 [TBL] [Abstract][Full Text] [Related]
12. Radiographic lung disease and response of persistent pulmonary hypertension to mean airway pressure and alkalosis. Deluga KS; Schlesinger AE Pediatr Pulmonol; 1994 Apr; 17(4):239-45. PubMed ID: 8208595 [TBL] [Abstract][Full Text] [Related]
13. Follow-up of 5- to 11-year-old children treated for persistent pulmonary hypertension of the newborn. Eriksen V; Nielsen LH; Klokker M; Greisen G Acta Paediatr; 2009 Feb; 98(2):304-9. PubMed ID: 18976361 [TBL] [Abstract][Full Text] [Related]
14. Morphometric analysis of the lung vasculature after extracorporeal membrane oxygenation treatment for pulmonary hypertension in newborns. van Heijst A; Haasdijk R; Groenman F; van der Staak F; Hulsbergen-van de Kaa C; de Krijger R; Tibboel D Virchows Arch; 2004 Jul; 445(1):36-44. PubMed ID: 15175881 [TBL] [Abstract][Full Text] [Related]
15. Developmental outcomes in persistent pulmonary hypertension treated with nitric oxide therapy. Hosono S; Ohno T; Kimoto H; Shimizu M; Takahashi S; Harada K Pediatr Int; 2009 Feb; 51(1):79-83. PubMed ID: 19371283 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. Rosenberg AA; Kennaugh JM; Moreland SG; Fashaw LM; Hale KA; Torielli FM; Abman SH; Kinsella JP J Pediatr; 1997 Jul; 131(1 Pt 1):70-5. PubMed ID: 9255194 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of minor neurologic deficits in a long-term neurodevelopmental follow-up of children with severe persistent pulmonary hypertension of the newborn: a cohort study. Berti A; Janes A; Furlan R; Macagno F Ital J Pediatr; 2010 Jun; 36():45. PubMed ID: 20540801 [TBL] [Abstract][Full Text] [Related]
18. Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health. Khorana M; Yookaseam T; Layangool T; Kanjanapattanakul W; Paradeevisut H J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S64-73. PubMed ID: 22043756 [TBL] [Abstract][Full Text] [Related]
19. Clinical experiences with high-frequency oscillatory ventilation in newborns with severe respiratory distress syndrome. Vierzig A; Günther M; Kribs A; Roth B Crit Care Med; 1994 Sep; 22(9 Suppl):S83-7. PubMed ID: 8070275 [TBL] [Abstract][Full Text] [Related]
20. Developmental follow-up of hyperventilated neonates: preliminary observations. Brett C; Dekle M; Leonard CH; Clark C; Sniderman S; Roth R; Ballard R; Clyman R Pediatrics; 1981 Oct; 68(4):588-91. PubMed ID: 7322695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]